Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/121905
Full metadata record
DC FieldValueLanguage
dc.creatorMaria Teresa Pardal Monteiro Coelho
dc.date.accessioned2019-08-14T23:12:52Z-
dc.date.available2019-08-14T23:12:52Z-
dc.date.issued2019-07-15
dc.date.submitted2019-08-14
dc.identifier.othersigarra:346407
dc.identifier.urihttps://hdl.handle.net/10216/121905-
dc.language.isoeng
dc.rightsopenAccess
dc.subjectCiências da saúde
dc.subjectHealth sciences
dc.titleDisease modifying therapies for attr amyloidoses: clinical development of new drugs and impact on the natural history of the disease
dc.typeTese
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar
dc.identifier.tid101439938
dc.subject.fosCiências médicas e da saúde::Ciências da saúde
dc.subject.fosMedical and Health sciences::Health sciences
thesis.degree.disciplineCiências Médicas
thesis.degree.grantorInstituto de Ciências Biomédicas Abel Salazar
thesis.degree.grantorUniversidade do Porto
thesis.degree.level2
Appears in Collections:ICBAS - Tese

Files in This Item:
File Description SizeFormat 
346407.pdfDisease modifying therapies for attr amyloidoses: clinical development of new drugs and impact on the natural history of the disease13.17 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.